Market Closed - Börse Stuttgart 20:55:50 19/06/2026 BST 5-day change 1st Jan Change
0.003000 EUR 0.00% Intraday chart for MagForce AG 0.00% +50.00%
1 month-14.29%
3 months-33.33%
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"
Current month-25.00%
1 month-14.29%
3 months-33.33%
6 months+50.00%
Current year+50.00%
1 week 0
Extreme 0.003
0
1 month 0
Extreme 0.003
0
Current year 0
Extreme 0.001
0.02
1 year 0
Extreme 0.001
0.02
3 years 0
Extreme 0.0002
0.02
5 years 0
Extreme 0.0002
0.02
10 years 0
Extreme 0.0002
0.02
Manager TitleAgeSince
Chief Executive Officer 86 31/08/2013
Director of Finance/CFO 54 30/09/2012
Director TitleAgeSince
Chairman 54 11/08/2021
Director/Board Member 45 -
Director/Board Member 54 -
Date Insider Type Main position Quantity % Market Cap.
15/12/20Buy

Chief Executive Officer

250,000 0.9045%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-45.45%-11.76% 105K
+1.44%+1.71%-10.98%-6.19% 43.13B
+3.31%+5.93%+310.97%+534.70% 34.65B
+2.84%+2.14%+9.34%+41.02% 30.03B
-1.70%-7.54%+8.43%-21.94% 28B
-1.90%-1.56%+10.24%+21.21% 24.45B
-0.14%+5.86% - - 14.34B
+0.68%-1.53%+48.76%+104.27% 13.14B
-0.57%-2.43%+5.08%+4.79% 12.53B
-0.26%+1.15%+98.13%+80.47% 12.25B
Average +0.37%+0.66%+48.28%+82.95% 21.25B
Weighted average by Cap. +0.77%+1.27%+65.47%+110.06%

Financials

2020 2021
Net sales 1.5M 1.72M 1.39M 1.3M 2.44M 163M 2.46M 16.51M 6.4M 80.02M 6.47M 6.33M 278M 1.08M 1.24M 998K 934K 1.75M 117M 1.76M 11.83M 4.59M 57.38M 4.64M 4.54M 199M
Net income 14.75M 16.91M 13.66M 12.79M 23.98M 1.6B 24.12M 162M 62.79M 786M 63.49M 62.13M 2.73B -10.57M -12.13M -9.79M -9.17M -17.19M -1.14B -17.3M -116M -45.03M -563M -45.52M -44.55M -1.96B
Net Debt - -
Logo MagForce AG
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
Employees
33
Date Price Change Volume
19/06/26 0.003000 0.00% 400
18/06/26 0.003000 0.00% 150
17/06/26 0.003000 0.00% 0
16/06/26 0.003000 0.00% 1,400
15/06/26 0.003000 0.00% 0
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!